Adial Pharmaceuticals Statistics
Total Valuation
ADIL has a market cap or net worth of $4.31 million. The enterprise value is $419,079.
Important Dates
The last earnings date was Tuesday, March 4, 2025, before market open.
Earnings Date | Mar 4, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ADIL has 6.57 million shares outstanding. The number of shares has increased by 240.54% in one year.
Current Share Class | 6.57M |
Shares Outstanding | 6.57M |
Shares Change (YoY) | +240.54% |
Shares Change (QoQ) | +9.94% |
Owned by Insiders (%) | 1.31% |
Owned by Institutions (%) | 4.60% |
Float | 6.15M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.01 |
P/TBV Ratio | 1.03 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.16
Current Ratio | 4.16 |
Quick Ratio | 3.84 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -323.80% and return on invested capital (ROIC) is -127.04%.
Return on Equity (ROE) | -323.80% |
Return on Assets (ROA) | -105.88% |
Return on Invested Capital (ROIC) | -127.04% |
Return on Capital Employed (ROCE) | -203.65% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.64M |
Employee Count | 5 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.68% in the last 52 weeks. The beta is 1.13, so ADIL's price volatility has been higher than the market average.
Beta (5Y) | 1.13 |
52-Week Price Change | -50.68% |
50-Day Moving Average | 0.78 |
200-Day Moving Average | 0.98 |
Relative Strength Index (RSI) | 40.40 |
Average Volume (20 Days) | 73,664 |
Short Selling Information
The latest short interest is 549,373, so 8.36% of the outstanding shares have been sold short.
Short Interest | 549,373 |
Short Previous Month | 685,273 |
Short % of Shares Out | 8.36% |
Short % of Float | 8.94% |
Short Ratio (days to cover) | 0.24 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -8.28M |
Pretax Income | -8.69M |
Net Income | -13.20M |
EBITDA | -8.28M |
EBIT | -8.28M |
Earnings Per Share (EPS) | -$2.72 |
Full Income Statement Balance Sheet
The company has $3.75 million in cash and n/a in debt, giving a net cash position of $3.75 million or $0.57 per share.
Cash & Cash Equivalents | 3.75M |
Total Debt | n/a |
Net Cash | 3.75M |
Net Cash Per Share | $0.57 |
Equity (Book Value) | 4.07M |
Book Value Per Share | 0.63 |
Working Capital | 3.08M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -6.92M |
Capital Expenditures | n/a |
Free Cash Flow | -6.92M |
FCF Per Share | -$1.05 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ADIL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -240.54% |
Shareholder Yield | -240.54% |
Earnings Yield | -316.52% |
FCF Yield | -166.02% |
Analyst Forecast
The average price target for ADIL is $8.00, which is 1,119.51% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $8.00 |
Price Target Difference | 1,119.51% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on August 7, 2023. It was a reverse split with a ratio of 0.04:1.
Last Split Date | Aug 7, 2023 |
Split Type | Reverse |
Split Ratio | 0.04:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |